atezolizumab in metastatic tnbc: long-term clinical outcomes and biomarker analyses
Published 7 years ago • 686 plays • Length 3:13Download video MP4
Download video MP3
Similar videos
-
4:25
biomarkers of systemic inflammation linked to reduced clinical activity of atezolizumab monother...
-
4:38
alice: atezolizumab immunogenic chemotherapy in metastatic tnbc
-
5:59
impassion130: atezolizumab and nab-paclitaxel in triple-negative breast cancer
-
4:49
adding atezolizumab to adjuvant chemotherapy for stage ii and iii triple-negative breast cancer ...
-
7:08
impassion130: results of atezolizumab plus nab-paclitaxel for frontline tnbc
-
6:46
combining atezolizumab to neoadjuvant chemotherapy does not improve pathologic complete response...
-
5:28
evaluating the combination of atezolizumab with neoadjuvant chemotherapy for the treatment of tr...
-
5:31
addition of atezolizumab to chemotherapy after surgery does not improve survival for triple nega...
-
5:48
considerations for ngs testing in mtnbc
-
6:20
atezolizumab for locally advanced or metastatic pd-l1-selected nsclc
-
4:56
results from the impassion 130 trial treating metastatic breast cancer
-
7:19
impassion130 trial: os updates in metastatic tnbc
-
1:03
dr. kalinsky on clinical impact of atezolizumab combo in tnbc
-
1:35
longer overall survival in metastatic tnbc with pembrolizumab - medpage today
-
6:06
atezolizumab monotherapy vs docetaxel in 2nd and 3rd line nsclc
-
0:59
impassion130 data demonstrate clinical benefit for immunotherapy in metastatic tnbc
-
1:07
neotrip: efs in neoadjuvant atezolizumab with taxane/carboplatin ± anthracycline in high-risk tnbc
-
4:53
results from the impassion130 trial for triple-negative breast cancer
-
4:15
impassion130: atezolizumab (atezo) nab-paclitaxel (nab-p) vs placebo nab-p in treatment-naiv...